celecoxib has been researched along with Cystic Fibrosis in 1 studies
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, PX | 1 |
| Cheng, J | 1 |
| Zou, S | 1 |
| D'Souza, AD | 1 |
| Koff, JL | 1 |
| Lu, J | 1 |
| Lee, PJ | 1 |
| Krause, DS | 1 |
| Egan, ME | 1 |
| Bruscia, EM | 1 |
1 other study available for celecoxib and Cystic Fibrosis
| Article | Year |
|---|---|
Pharmacological modulation of the AKT/microRNA-199a-5p/CAV1 pathway ameliorates cystic fibrosis lung hyper-inflammation.
Topics: Animals; Caveolin 1; Celecoxib; Cystic Fibrosis; Humans; Inflammation; Lung; Macrophages; Mice, Inbr | 2015 |